Trulieve Cannabis Corp. Announces Significant Share Repurchase Program
Key Points for Investors
- Share Repurchase Authorization: Trulieve Cannabis Corp. (“Trulieve” or “the Company”) announced that its Board of Directors has authorized a share repurchase program.
- Repurchase Limits: The Company may repurchase up to the lesser of \$50 million in aggregate value or 8,495,038 subordinate voting shares, representing 5% of the Company’s issued and outstanding subordinate voting shares as of June 8, 2026.
- Program Duration: The repurchase program will run for 12 months, expiring on June 16, 2027.
- Share Cancellation: All subordinate voting shares purchased under this program will be cancelled.
- Flexibility: The program does not obligate the Company to acquire any specific number of shares and may be suspended, modified, or discontinued at any time at the Company’s discretion.
- Execution: Repurchases will be carried out in accordance with applicable securities laws and regulations.
- Rationale: CEO Kim Rivers stated that the program reflects confidence in Trulieve’s long-term value and a disciplined approach to capital allocation. The Company views share repurchases as an important tool to deliver value to shareholders, especially when market conditions present a compelling opportunity, while maintaining flexibility to invest in growth and strengthen its balance sheet.
Implications for Shareholders
- Potential Share Price Impact: Share repurchase programs are generally viewed positively by investors, as they can signal management’s confidence in the business, improve earnings per share, and provide support to the share price during periods of market volatility.
- Reduction in Outstanding Shares: Cancelling repurchased shares will reduce the total number of subordinate voting shares outstanding, potentially increasing the value of remaining shares.
- Capital Allocation: The program underscores Trulieve’s commitment to disciplined capital allocation, balancing shareholder returns with investments in growth and financial strength.
- No Guarantee of Repurchases: Shareholders should note that the Company is not obligated to complete the full repurchase amount and can suspend or discontinue the program at any time.
Forward-Looking Statements and Risks
The announcement includes forward-looking statements regarding the Company’s intentions and expectations around the repurchase program. Actual results may differ due to a variety of risks and uncertainties, including those detailed in Trulieve’s Annual Report on Form 10-K and other SEC filings. Investors should not place undue reliance on these statements and are encouraged to review the Company’s risk disclosures.
About Trulieve Cannabis Corp.
Trulieve is a vertically integrated cannabis company and multi-state operator in the U.S., with established medical marijuana operations in Florida, Georgia, Pennsylvania, and West Virginia. The Company is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, visit Trulieve.com.
Investor and Media Contact
Christine Hersey, Chief Corporate Affairs and Strategy Officer
+1 (424) 202-0210
[email protected]
Disclaimer: This article is for informational purposes only and does not constitute investment advice. All forward-looking statements are subject to risks and uncertainties. Investors should consult official filings and their financial advisors before making any investment decisions.
